Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for acute myeloid leukemia with CBFA2T3-GLIS2 fusion has been reported in the published literature.
No clinical trials have been registered for acute myeloid leukemia with CBFA2T3-GLIS2 fusion.
16 publications have been identified in PubMed for acute myeloid leukemia with CBFA2T3-GLIS2 fusion. Research spans Review / Meta-Analysis (31%), Basic Science / Preclinical (25%), and Case Report / Case Series (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 5 | 31% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 8:44 AM UTC
Common questions about acute myeloid leukemia with CBFA2T3-GLIS2 fusion
Laboratory research
4 |
25% |
Patient case studies | 2 | 13% |
New treatment approaches | 2 | 13% |
Other research | 1 | 6% |
Testing and diagnosis research | 1 | 6% |
Disease patterns and progression | 1 | 6% |
Gonzales F (2026). [PMID: 41507381](https://pubmed.ncbi.nlm.nih.gov/41507381/). *Leukemia*. [Gene Therapy / Novel Therapeutics]
Capdevielle C (2026). [PMID: 41058336](https://pubmed.ncbi.nlm.nih.gov/41058336/). *Trends Mol Med*. [Review / Meta-Analysis]
Lee Y (2026). [PMID: 41960216](https://pubmed.ncbi.nlm.nih.gov/41960216/). *EJHaem*. [Diagnostic / Biomarker]
Choudhury SR (2026). [PMID: 41141393](https://pubmed.ncbi.nlm.nih.gov/41141393/). *Genes Dis*. [Basic Science / Preclinical]
Lin S (2026). [PMID: 41991315](https://pubmed.ncbi.nlm.nih.gov/41991315/). *Zhonghua Xue Ye Xue Za Zhi*. [Review / Meta-Analysis]
Umeda M (2025). [PMID: 39781610](https://pubmed.ncbi.nlm.nih.gov/39781610/). *Haematologica*. [Review / Meta-Analysis]
Lebedeva S (2025). [PMID: 40565358](https://pubmed.ncbi.nlm.nih.gov/40565358/). *Int J Mol Sci*. [Case Report / Case Series]
Egan G (2025). [PMID: 39808803](https://pubmed.ncbi.nlm.nih.gov/39808803/). *Blood*. [Review / Meta-Analysis]
Pigazzi M (2025). [PMID: 41348020](https://pubmed.ncbi.nlm.nih.gov/41348020/). *Hematology Am Soc Hematol Educ Program*. [Review / Meta-Analysis]
Hamdan H (2025). [PMID: 39866946](https://pubmed.ncbi.nlm.nih.gov/39866946/). *EJHaem*. [Epidemiology / Natural History]